Orgotein

CHEMBL2108545 Phase 4 Onaylandı Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

515.7 g/mol

LogP

—

Phase

4

A bovine superoxide dismutase enzyme with anti-inflammatory properties, investigated to treat conditions including interstitial cystitis, radiation-induced fibrosis, and arthritis. It scavenges free radicals and was used in some countries before being withdrawn over concerns about immune reactions.

Moleküler Ağırlık

515,7000 g/mol

TPSA

0,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

[Cu+2].[Cu+2].[Cu+2].[Cu+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2]

InChI

InChI=1S/4Cu.4Zn/q8*+2

Molecular Formula

Cu4Zn4+16

HBD / HBA

- / -

Döndürülebilir Bağlar

0

Ağır Atomlar

8

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A bovine superoxide dismutase enzyme with anti-inflammatory properties, investigated to treat conditions including interstitial cystitis, radiation-induced fibrosis, and arthritis. It scavenges free radicals and was used in some countries before being withdrawn over concerns about immune reactions.

Yes, Orgotein is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108545. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 72941490. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Orgotein PillFYI'da

Hızlı Veriler

Formül: Cu4Zn4+16

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.